Moreover, in NPM-ALK+ (nucleophosmin-anaplastic lymphoma kinase) T-cell lymphoma, MZF1 reduces IGF-IR (the type I insulin-like growth factor receptor) expression by inhibiting its transcription [16]. This evidence concerns the gene ALK and T-cell non-Hodgkin lymphoma.